Consolidative radiation therapy may provide a significant benefit to patients with specific subtypes of diffuse large B-cell lymphoma. READ MORE
Opting to forgo radiotherapy can be considered in children with Hodgkin lymphoma who achieve metabolic remission on interim PET after ABVD chemotherapy.
Obese children and adolescents may suffer higher rates of treatment-related mortality after chemotherapy for acute myeloid leukemia.
Novel oral targeted therapies for the treatment of chronic lymphocytic leukemia could raise treatment costs by 600%.
Research in Review
Elevated expression levels of ETS2 were a strong predictor of prognosis in AML and should be used to guide treatment decisions.
Immunotherapy after complete remission in acute myeloid leukemia is associated with decreasing levels of regulatory T-cells, which leads to favorable clinical outcomes.
A new prognostic tool improves personalized treatment for patients with marginal zone lymphoma.
A recent report demonstrates the promise of programmed death inhibition in improving outcomes for patients with a rare, difficult-to-treat type of lymphoma.